A clinical study of Evenamide (NW-3509) in patients with schizophrenia not responding to clozapine.
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2018
At a glance
- Drugs Evenamide (Primary)
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Sponsors Newron Pharmaceuticals
- 13 Sep 2018 According to a Newron Pharmaceuticals media release, this study is expected to commence in H1 2019.
- 01 Mar 2018 According to a Newron Pharmaceuticals media release, this study is expected to commence towards the end of 2018.
- 13 Dec 2017 New trial record